Asklepios BioPharmaceutical
Stefan Oelrich has been a member of the Board of Management of Bayer AG and Head of the Pharmaceuticals Division, headquartered in Berlin, Germany, since November 1, 2018. He is also responsible for the region Latin America. After graduating from high school in Paris, France, he joined Bayer AG as a commercial trainee in 1989 and qualified as a commercial assistant in 1991.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Asklepios BioPharmaceutical
1 followers
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.